Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2010 (2010), Article ID 321061, 15 pages
http://dx.doi.org/10.1155/2010/321061
Research Article

Nitric Oxide Synthase Enzymes in the Airways of Mice Exposed to Ovalbumin: NOS2 Expression Is NOS3 Dependent

Pulmonary and Critical Care Medicine, School of Medicine, Genome and Biomedical Sciences Facility, Suite 6500, 451 Health Sciences Dr., University of California, Davis, CA 95616, USA

Received 17 February 2010; Revised 29 June 2010; Accepted 2 August 2010

Academic Editor: Jan van Amsterdam

Copyright © 2010 Jennifer M. Bratt et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. J. Kenyon, K. Gohil, and J. A. Last, “Susceptibility to ovalbumin-induced airway inflammation and fibrosis in inducible nitric oxide synthetase-deficient mice: mechanisms and consequences,” Toxicology and Applied Pharmacology, vol. 191, no. 1, pp. 2–11, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. N. J. Kenyon and J. A. Last, “Reversible and irreversible airway inflammation and fibrosis in mice exposed to inhaled ovalbumin,” Inflammation Research, vol. 54, no. 2, pp. 57–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Zimmermann, N. E. King, J. Laporte et al., “Dissection of experimental asthma with DNA microarray analysis identifies arginase in asthma pathogenesis,” Journal of Clinical Investigation, vol. 111, no. 12, pp. 1863–1874, 2003. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Kobayashi, Y. Nishimura, T. Yamashita, T. Nishiuma, M. Satouchi, and M. Yokoyama, “The effect of overexpression of endothelial nitric oxide synthase on eosinophilic lung inflammation in a murine model,” International Immunopharmacology, vol. 6, no. 7, pp. 1040–1052, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Shan, P. Carbonara, N. Karp, M. Tulic, Q. Hamid, and D. H. Eidelman, “Localization and distribution of NOS1 in murine airways,” Nitric Oxide - Biology and Chemistry, vol. 17, no. 1, pp. 25–32, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. O. Lundberg, M. T. Gladwin, A. Ahluwalia et al., “Nitrate and nitrite in biology, nutrition and therapeutics,” Nature Chemical Biology, vol. 5, no. 12, pp. 865–869, 2009. View at Publisher · View at Google Scholar · View at Scopus
  7. E. Å. Jansson, L. Huang, R. Malkey et al., “A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis,” Nature Chemical Biology, vol. 4, no. 7, pp. 411–417, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. , “ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005,” American Journal of Respiratory and Critical Care Medicine, vol. 171, no. 8, pp. 912–930, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Singh, D. Richards, R. G. Knowles et al., “Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 176, no. 10, pp. 988–993, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Cook, P. Vollenweider, B. Ménard, M. Egli, P. Nicod, and U. Scherrer, “Increased eNO and pulmonary iNOS expression in eNOS null mice,” European Respiratory Journal, vol. 21, no. 5, pp. 770–773, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. Togashi, M. Sasaki, E. Frohman et al., “Neuronal (type I) nitric oxide synthase regulates nuclear factorκB activity and immunologie (type II) nitric oxide synthase expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 6, pp. 2676–2680, 1997. View at Google Scholar · View at Scopus
  12. J. Zhen, H. Lu, X. Q. Wang, N. D. Vaziri, and X. J. Zhou, “Upregulation of endothelial and inducible nitric oxide synthase expression by reactive oxygen species,” American Journal of Hypertension, vol. 21, no. 1, pp. 28–34, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. C. R. Morris, M. T. Gladwin, and G. J. Kato, “Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disorders,” Current Molecular Medicine, vol. 8, no. 7, pp. 620–632, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. Cosby, K. S. Partovi, J. H. Crawford et al., “Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation,” Nature Medicine, vol. 9, no. 12, pp. 1498–1505, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. P. B. Soeters, M. M. Hallemeesch, M. J. Bruins, H. M. H. Van Eijk, and N. E. P. Deutz, “Quantitative in vivo assessment of arginine utilization and nitric oxide production in endotoxemia,” American Journal of Surgery, vol. 183, no. 4, pp. 480–488, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. L. Connelly, M. Palacios-Callender, C. Ameixa, S. Moncada, and A. J. Hobbs, “Biphasic regulation of NF-κB activity underlies the pro- and anti-inflammatory actions of nitric oxide,” Journal of Immunology, vol. 166, no. 6, pp. 3873–3881, 2001. View at Google Scholar · View at Scopus
  17. F. Gobeil Jr., S. G. Bernier, A. Vazquez-Tello et al., “Modulation of pro-inflammatory gene expression by nuclear lysophosphatidic acid receptor type-1,” Journal of Biological Chemistry, vol. 278, no. 40, pp. 38875–38883, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. J. M. Bratt, L. M. Franzi, A. L. Linderholm, M. S. Last, N. J. Kenyon, and J. A. Last, “Arginase enzymes in isolated airways from normal and nitric oxide synthase 2-knockout mice exposed to ovalbumin,” Toxicology and Applied Pharmacology, vol. 234, no. 3, pp. 273–280, 2009. View at Publisher · View at Google Scholar · View at Scopus
  19. R. Ten Broeke, R. De Crom, R. Van Haperen et al., “Overexpression of endothelial nitric oxide synthase suppresses features of allergic asthma in mice,” Respiratory Research, vol. 7, article no. 58, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. N. J. Kenyon, A. Van Der Vliet, B. C. Schock, T. Okamoto, G. M. McGrew, and J. A. Last, “Susceptibility to ozone-induced acute lung injury in iNOS-deficient mice,” American Journal of Physiology, vol. 282, no. 3, pp. L540–L545, 2002. View at Google Scholar · View at Scopus
  21. J. Temelkovski, S. P. Hogan, D. P. Shepherd, P. S. Foster, and R. K. Kumar, “An improved murine model of asthma: selective airway inflammation, epithelial lesions and increased methacholine responsiveness following chronic exposure to aerosolised allergen,” Thorax, vol. 53, no. 10, pp. 849–856, 1998. View at Google Scholar · View at Scopus
  22. N. J. Kenyon, R. W. Ward, and J. A. Last, “Airway fibrosis in a mouse model of airway inflammation,” Toxicology and Applied Pharmacology, vol. 186, no. 2, pp. 90–100, 2003. View at Publisher · View at Google Scholar · View at Scopus
  23. P. E. Silkoff, S. Wakita, J. Chatkin et al., “Exhaled nitric oxide after β2-agonist inhalation and spirometry in asthma,” American Journal of Respiratory and Critical Care Medicine, vol. 159, no. 3, pp. 940–944, 1999. View at Google Scholar · View at Scopus
  24. N. J. Kenyon, M. S. Last, J. P. Eiserich, B. M. Morrissey, L. M. Temple, and J. A. Last, “Differentiation of the roles of NO from airway epithelium and inflammatory cells in ozone-induced lung inflammation,” Toxicology and Applied Pharmacology, vol. 215, no. 3, pp. 250–259, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. K. Kobayashi, Y. Nishimura, T. Yamashita, T. Nishiuma, M. Satouchi, and M. Yokoyama, “The effect of overexpression of endothelial nitric oxide synthase on eosinophilic lung inflammation in a murine model,” International Immunopharmacology, vol. 6, no. 7, pp. 1040–1052, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. H. M. Razavi, J. A. Hamilton, and Q. Feng, “Modulation of apoptosis by nitric oxide: implications in myocardial ischemia and heart failure,” Pharmacology and Therapeutics, vol. 106, no. 2, pp. 147–162, 2005. View at Publisher · View at Google Scholar · View at Scopus
  27. Y.-M. Kim, R. V. Talanian, and T. R. Billiar, “Nitric oxide inhibits apoptosis by preventing increases in caspase-3- like activity via two distinct mechanisms,” Journal of Biological Chemistry, vol. 272, no. 49, pp. 31138–31148, 1997. View at Publisher · View at Google Scholar · View at Scopus
  28. H. E. Marshall and J. S. Stamler, “Nitrosative stress-induced apoptosis through inhibition of NF-κB,” Journal of Biological Chemistry, vol. 277, no. 37, pp. 34223–34228, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Azad, V. Vallyathan, L. Wang et al., “S-nitrosylation of Bcl-2 inhibits its ubiquitin-proteasomal degradation: a novel antiapoptotic mechanism that suppresses apoptosis,” Journal of Biological Chemistry, vol. 281, no. 45, pp. 34124–34134, 2006. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Steudel, M. Kirmse, J. Weimann, R. Ullrich, J. Hromi, and W. M. Zapol, “Exhaled nitric oxide production by nitric oxide synthase-deficient mice,” American Journal of Respiratory and Critical Care Medicine, vol. 162, no. 4, pp. 1262–1267, 2000. View at Google Scholar · View at Scopus
  31. A. Samb, M. Pretolani, A.-T. Dinh-Xuan et al., “Decreased pulmonary and tracheal smooth muscle expression and activity of type 1 nitric oxide synthase (nNOS) after ovalbumin immunization and multiple aerosol challenge in guinea pigs,” American Journal of Respiratory and Critical Care Medicine, vol. 164, no. 1, pp. 149–154, 2001. View at Google Scholar · View at Scopus
  32. H. Maarsingh, J. Leusink, I. S. T. Bos, J. Zaagsma, and H. Meurs, “Arginase strongly impairs neuronal nitric oxide-mediated airway smooth muscle relaxation in allergic asthma,” Respiratory Research, vol. 7, no. 1, article no. 1, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. G. T. De Sanctis, J. A. MacLean, K. Hamada et al., “Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma,” Journal of Experimental Medicine, vol. 189, no. 10, pp. 1621–1629, 1999. View at Publisher · View at Google Scholar · View at Scopus
  34. F. L. M. Ricciardolo, P. J. Sterk, B. Gaston, and G. Folkerts, “Nitric oxide in health and disease of the respiratory system,” Physiological Reviews, vol. 84, no. 3, pp. 731–765, 2004. View at Publisher · View at Google Scholar · View at Scopus
  35. N. L. Reynaert, K. Ckless, S. H. Korn et al., “Nitric oxide represses inhibitory κB kinase through S-nitrosylation,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 24, pp. 8945–8950, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. P. A. Vo, B. Lad, J. A. P. Tomlinson, S. Francis, and A. Ahluwalia, “Autoregulatory role of endothelium-derived nitric oxide (NO) on lipopolysaccharide-induced vascular inducible NO synthase expression and function,” Journal of Biological Chemistry, vol. 280, no. 8, pp. 7236–7243, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. S. K. Park, H. L. Lin, and S. Murphy, “Nitric oxide regulates nitric oxide synthase-2 gene expression by inhibiting NF-κB binding to DNA,” Biochemical Journal, vol. 322, no. 2, pp. 609–613, 1997. View at Google Scholar · View at Scopus
  38. H. E. Marshall and J. S. Stamler, “Inhibition of NF-κB by S-nitrosylation,” Biochemistry, vol. 40, no. 6, pp. 1688–1693, 2001. View at Publisher · View at Google Scholar · View at Scopus
  39. Z. T. Kelleher, A. Matsumoto, J. S. Stamler, and H. E. Marshall, “NOS2 regulation of NF-κB by S-nitrosylation of p65,” Journal of Biological Chemistry, vol. 282, no. 42, pp. 30667–30672, 2007. View at Publisher · View at Google Scholar · View at Scopus
  40. H.-B. Peng, P. Libby, and J. K. Liao, “Induction and stabilization of IκBα by nitric oxide mediates inhibition of NF-κB,” Journal of Biological Chemistry, vol. 270, no. 23, pp. 14214–14219, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. K. Katsuyama, M. Shichiri, F. Marumo, and Y. Hirata, “NO inhibits cytokine-induced iNOS expression and NF-κB activation by interfering with phosphorylation and degradation of IκB-α,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 18, no. 11, pp. 1796–1802, 1998. View at Google Scholar · View at Scopus